Biased Agonism/Antagonism of Cardiovascular GPCRs for Heart Failure Therapy
- 1 January 2018
- book chapter
- Published by Elsevier
- Vol. 339, 41-61
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Crystal Structures of a Stabilized β1-Adrenoceptor Bound to the Biased Agonists Bucindolol and CarvedilolStructure, 2012
- Alpha-1-adrenergic receptors: Targets for agonist drugs to treat heart failureJournal of Molecular and Cellular Cardiology, 2011
- SUMO1-dependent modulation of SERCA2a in heart failureNature, 2011
- Therapeutic potential of β-arrestin- and G protein-biased agonistsTrends in Molecular Medicine, 2011
- Adrenal Beta-Arrestin 1 Inhibition In Vivo Attenuates Post-Myocardial Infarction Progression to Heart Failure and Adverse Remodeling Via Reduction of Circulating Aldosterone LevelsJACC, 2011
- Physiological and pharmacological implications of beta-arrestin regulationPharmacology & Therapeutics, 2009
- β-Blockers alprenolol and carvedilol stimulate β-arrestin-mediated EGFR transactivationProceedings of the National Academy of Sciences, 2008
- Carvedilol increases blood pressure response to phenylephrine infusion in heart failure subjects with systolic dysfunction: Evidence of improved vascular α1-adrenoreceptor signal transductionAmerican Heart Journal, 2008
- Apelin increases contractility in failing cardiac muscleEuropean Journal of Pharmacology, 2006
- β-Arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytesProceedings of the National Academy of Sciences, 2006